Latest news

Thumbnail image for SMC endorses EUSA Pharma’s Qarziba

SMC endorses EUSA Pharma’s Qarziba

A medicine used to treat a rare cancer that predominantly occurs in very young children is to be routinely funded on the NHS in Scotland.

13th November 2018

Thumbnail image for AstraZeneca divests US rights to Synagis

AstraZeneca divests US rights to Synagis

Swedish Orphan Biovitrum AB has entered into an agreement to buy US rights to AstraZeneca’s Synagis, licensed for the prevention of serious lower respiratory tract infection caused by respiratory syncytial virus (RSV).

13th November 2018

Thumbnail image for MSD’s Keytruda approved for liver cancer

MSD’s Keytruda approved for liver cancer

US regulators have expanded the use of MSD’s anti-PD-1 therapy Keytruda to include treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib.

12th November 2018

Thumbnail image for MPs order release of documents on negotiations for Vertex’ CF drugs

MPs order release of documents on negotiations for Vertex’ CF drugs

The UK House of Commons' Health and Social Care Committee has requested documents and evidence from Vertex Pharmaceuticals, NHS England and the National Institute for Health and Care Excellence (NICE) regarding ongoing and lengthy negotiations about NHS funding for the firm’s cystic fibrosis treatments.

12th November 2018

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download